Chikungunya Outbreak in Italy: What You Need to Know
"A new cluster of autochthonous chikungunya virus has been identified in Italy's Latium region, raising concerns about the spread of this mosquito-borne disease. Here's what you need to know to stay informed and protected."
Chikungunya virus (CHIKV) is back in the news with a localized transmission confirmed in the Latium region of Italy. Two related clusters have emerged in the cities of Anzio and Rome, marking the second known autochthonous outbreak of CHIKV in Italy. The first occurred in 2007 in the Emilia Romagna region.
Between these two Italian epidemics, other transmissions were reported in France in 2010, 2014, and 2017, highlighting the ongoing concern about this infection. The primary culprit? The Aedes albopictus mosquito, which has established itself across the Mediterranean basin and beyond.
Currently, Aedes albopictus is assumed to be the vector in the Italian outbreak, as Aedes aegypti mosquitoes are not present in the country. The Laboratory of Virology of Lazzaro Spallanzani National Institute for Infectious Disease (INMI) in Rome, is responsible for CHIKV diagnosis and surveillance in the Latium region.
Decoding the Chikungunya Outbreak: Key Facts & Prevention

CHIKV diagnosis relies on detecting the viral genome via real-time reverse transcription PCR (RT-PCR) and identifying virus-specific antibodies through serologic tests. Scientists analyze endpoint PCR amplicons from selected patients to confirm the virus's identity, verified by real-time RT-PCR, and attempt virus isolation whenever possible.
- Symptoms: Fever, joint pain, headache, muscle pain, joint swelling, or rash.
- Prevention: Use insect repellent, wear long sleeves and pants, and control mosquitoes indoors and outdoors.
- Seek Medical Attention: If you develop symptoms of chikungunya, see your doctor.
Genetic Insights and Future Research
Genetic sequencing reveals the virus in the Latium outbreak belongs to the East/Central/South African (ECSA) clade, similar to the 2007 Italy outbreak. However, the current sequences fall into a separate branch, suggesting a more recent origin. Unlike the 2007 outbreak, the E1 sequences from the ongoing outbreak lack the A226V mutation. Further research will explore the implications of this and other genetic signatures.